COVID-19 posed a new challenge to the global medical science, and not all traditional approaches used earlier, for example, in the treatment of SARS and other viral infections, were acceptable On March 20, 2020, the first fatal outcome from a new coro-navirus infection was registered in Moscow By the time the article was published (6 weeks later) more than 1000 deaths were reg-istered Taking into account the fact that there is still a growth in the number of patients and, consequently, deaths, the analysis of lethal outcomes of the first (in chronological order of patients) seems to be extremely relevant As information about a new coro-navirus infection accumulates, our actions and recommendations on its treatment will change Most drugs to treat the new coro-navirus infection are still under clinical trials A vaccine has not been developed, and data on the use of plasma, convalescents, hydroxychloroquine and a number of other drugs are insufficient to provide recommendations that meet the principles of evidence-based medicine We believe that the analysis of the first 157 fatal cases of a new coronavirus infection is only the first step in the for-mation of carefully verified treatment recommendations © 2020, Media Sphera Publishing Group All rights reserved
Analysis of the first fatal outcome cases of a new coronavirus infection covid-19 in medical organizations of the state healthcare system of Moscow